SCHEMBL219786

SCHEMBL219786

C1N=C2N=NN=C2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219381 0.59
SCHEMBL2346494 0.57
SCHEMBL218204 0.54
SCHEMBL56190 0.34
SCHEMBL4601547 0.26
SCHEMBL8671944 0.26
Ammonia Solution, Strong SCHEMBL22987286 0.22
SCHEMBL10396329 0.22
SCHEMBL8227000 0.22
SCHEMBL15913 0.22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111233850-A Naphthol derivative containing benzothiazole amino and heteroaryl, preparation method and application thereof 南开大学 2020-06-05 CN claimed
WO-2019217822-A1 COMPOUNDS AND METHODS OF USING COMPOUNDS FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY CONDITIONS CHROMOCELL CORPORATION (US) 2019-11-14 WO claimed
EP-3193610-A1 SELECTIVE NAV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES Chromocell Corporation (US) 2017-07-26 EP claimed
EP-2336315-B1 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION AS (DK) 2017-07-19 EP claimed
WO-2016040315-A1 SELECTIVE NAV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES CHROMOCELL CORPORATION (US) 2016-03-17 WO claimed
EP-2336315-A2 Enzymatic encoding methods for efficient synthesis of large libraries Nuevolution A/S (DK) 2011-06-22 EP claimed
CN-110740996-B Covalent small molecule DCN1 inhibitors and methods of treatment using the same 密执安大学评议会 2024-01-09 CN disclosed
US-11702652-B2 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION A/S (DK) 2023-07-18 US disclosed
CN-116157382-A Material for metal patterning, amine compound, electronic device, and method for forming metal pattern 东曹株式会社 2023-05-23 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-111233850-B Naphthol derivative containing benzothiazole amino and heteroaryl and preparation method and application thereof 南开大学 2022-09-23 CN disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
CN-109195602-B Symmetrical or semi-symmetrical compounds useful as immunomodulators 上海齐鲁制药研究中心有限公司 2022-01-07 CN disclosed
US-20090247736-A1 Luminous Compound Containing Lanthanide Ion FUJIFILM CORPORATION (JP) 2009-10-01 US disclosed
WO-2008155666-A2 HETEROARYLAMIDE-SUBSTITUTED PYRIMIDONE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SANOFI-AVENTIS (FR) 2008-12-24 WO disclosed
WO-2008155668-A2 HETEROARYLAMIDE PYRIMIDONE COMPOUNDS SANOFI-AVENTIS (FR) 2008-12-24 WO disclosed
EP-1992624-A1 Heteroarylamide pyrimidone compounds Sanofi-Aventis (FR) 2008-11-19 EP disclosed
EP-1992621-A1 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases Sanofi-Aventis (FR) 2008-11-19 EP disclosed
EP-1877517-A2 LUMINOUS COMPOUND CONTAINING LANTHANIDE ION FUJIFILM CORPORATION (JP) 2008-01-16 EP disclosed
WO-2006101217-A2 LUMINOUS COMPOUND CONTAINING LANTHANIDE ION FUJIFILM CORPORATION (JP) 2006-09-28 WO disclosed